SOCMA Renews Call For Permanent Security Standards
Published: 03-Mar-2010
The Society of Chemical Manufacturers and Affiliates (SOCMA), in testimony to a key Senate panel, has again urged Congress to make the current risk-based chemical facility security standards permanent, or at least reauthorize the program until 2015.
Stephen Poorman, international EHS&S manager of Fujifilm Imaging Colorants, in remarks to a hearing before the Senate Committee on Homeland Security and Governmental Affairs, encouraged lawmakers to preserve the progress made under the current regulatory program.
Mr Poorman argued that Congress can assure the continued success of the existing program by passing S. 2996, the Continuing Chemical Facilities Antiterrorism Security Act, introduced by Senator Susan Collins (R-ME), together with Senators Mark Pryor (D-AR), George Voinovich (R-OH), and Mary Landrieu (D-LA).
Specifically, the bill’s requirement of mandatory implementation of so-called inherently safer technology (IST) would shift DHS’s focus from securing our industry against terrorism to conducting engineering and chemistry assessments, while potentially phasing out legitimate products. He noted that, in contrast to the bipartisan Senate bill, the House version passed without a single minority vote and in spite of expert testimony advising against mandatory IST.
He said: “It is a wonder why IST proponents still support such a provision when there is so much uncertainty about the concept and how DHS could apply it – and during a historic economic recession in which our nation’s unemployment rate still stands at nearly 10%.
“Spending money to comply with new regulations necessarily causes companies to assess how they will pay for it. There isn’t much available capital these days for manufacturers to take on new regulations aimed at their very livelihood, especially small manufacturers.”
Network Sites

Suppliers To This Sector
Browse A-Z
Carpmaels & Ransford
Patent and Trade Mark Attorneys ...
GxPi
Consulting and Compliant Document Management Solutions ...
Cutting Edge Information
Pharmaceutical Business Intelligence Reports ...
Pharmaceutical Development Services
Pharmaceutical, Regulatory and Medical Device Consultancy ...
Luzzatto & Luzzatto
Patent Attorneys ...
Innovaro
Partnering, Licensing and Business Development for the Life Science and Biopharmaceutical Industries...
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
What is ZeoCool?
ZeoCool is a revolutionary step in the design of temperature controlled packaging. Control ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
ValiChrom - Validation and Scale Down Modelling Columns
The first purpose designed LC columns for reliable validation results. For more informatio ...


Delicious
Digg
LinkedIn
Reddit
Stumble
Viadeo
Mail sent successfully